NHS patients gain access to COVID-19 treatment Ronapreve
Ronapreve will be targeted at hospitalised patients who have not mounted an antibody response against COVID-19
Read More
Tag: Ronapreve
- Francis Crick, UCL and AZ identify why treatment fails for NSCLC patients
- Royal Marsden launches first UK genome testing facility to improve testing for cancer
- Sysmex receives Longitude Prize on AMR for antimicrobial testing system
- LifeArc funds new projects to address and prevent global threat of dengue fever
- New study reveals how brain cell communication is linked to Alzheimer’s disease
